Back
Science

Study examines effect of daily orange consumption on lipid profiles in MASLD patients

Generated on: Last updated: 1 sources
View source

Study Explores Effects of Daily Orange Consumption on Liver Disease Patients

A recent study published in the journal Nutrients evaluated the impact of daily "Navelina" orange consumption on serum lipid profiles in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

The study involved 60 participants aged 30-65 with MASLD, recruited from a nutrition clinic in Italy between February and November 2023. Participants were randomly assigned to one of two groups: a treatment arm that consumed 400 grams of oranges daily, and a control arm that abstained from oranges. All participants received general dietary recommendations. Blood samples were analyzed for fatty acids and biochemical markers at the start of the study and after four weeks.

Generalized estimating equation modeling showed no statistically significant time-by-treatment interaction across lipid or biochemical outcomes.

Key Findings

While the primary analysis did not show statistically significant effects, several noteworthy trends and correlations were observed:

  • A borderline trend suggested a directional reduction in total cholesterol in the orange consumption group relative to the control group.
  • In the treatment arm, there was a reduction in arachidonic acid and the arachidonic acid/eicosapentaenoic acid (AA/EPA) ratio, indicating a slight, non-significant shift toward a potentially anti-inflammatory fatty acid profile.
  • Total cholesterol and low-density lipoprotein (LDL) decreased, while high-density lipoprotein (HDL) increased in the treatment arm, though none of these changes reached statistical significance.

Correlation analyses within the treatment arm revealed several significant associations:

  • Oleic acid and monounsaturated fatty acids were inversely correlated with HDL.
  • The AA/EPA ratio showed a stronger inverse association with HDL.
  • Eicosapentaenoic acid (EPA) and n-3 polyunsaturated fatty acids were positively correlated with HDL.

In the control arm, the only significant correlation found was an inverse relationship between oleic acid, monounsaturated fatty acids, and total cholesterol.

Background and Context

MASLD, formerly known as non-alcoholic fatty liver disease (NAFLD), is a condition closely linked to metabolic syndrome, visceral obesity, and type 2 diabetes. Lifestyle and dietary changes are considered cornerstone therapies for managing the disease.

This study builds on prior research which showed that supplementing the diet with 400 grams per day of "Navelina" oranges for four weeks produced a measurable reduction in hepatic steatosis (liver fat) in MASLD patients.

Study Limitations

The researchers noted several important limitations to consider when interpreting the results:

  • The study had a relatively small sample size and a short four-week duration.
  • The correlation analysis is exploratory and does not establish causality.
  • Post hoc analysis was limited to specific fatty acid changes and does not confirm the overall power of the study or allow for causal inference.

Conclusions

Daily "Navelina" orange consumption was associated with modest, non-significant changes in serum fatty acid profiles in patients with MASLD.

The findings offer preliminary insights into the potential effects of orange polyphenols on lipid metabolism. The researchers suggested that future studies could explore links between serum lipid profiles and inflammation or oxidative stress, and work to establish a dose-response curve for orange-derived polyphenols.